-
Can This Company's Birth Control Patch Disrupt The Contraceptive Market?
Tuesday, October 25, 2022 - 8:09am | 942Read More...From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive, the market is never in short supply of birth control products. While the issue of birth...
-
The Past Week's Notable Insider Buys Included Digitalbridge, Life Time, A SPAC And More
Saturday, October 16, 2021 - 1:15pm | 671Read More...Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain. With the new earnings season underway, this week's most notable insider purchases were made by 10% owners. A SPAC about to go public and a recent initial public offering prompted...
-
Agile Therapeutics Plunges After Company Prices A Stock Offering At $6.35 Per Share
Friday, January 22, 2016 - 2:39pm | 169Read More...Shares of Agile Therapeutics Inc (NASDAQ: AGRX) plunged to a 52-week low of $6.01 on Friday after the company announced a public offering of 5.512 million shares of its common stock at a price of $6.35 per share. Agile Therapeutics' stock closed at $7.06 on Thursday. The company disclosed...
